Medicinal Genomics
Liam K. has extensive experience in bioinformatics and research within the field of drug discovery and development. Currently serving as a Bioinformatics Scientist at Medicinal Genomics since December 2018, Liam K. previously held various roles including Junior Bioinformatician, Research and Development Scientist, and Research and Development Coop at the same company. Prior to this, Liam K. completed an internship at Medicinal Genomics and worked as a Research Assistant at the Center for Drug Discovery at Northeastern University, focusing on enzyme assays related to synthetic cannabinoids and CB receptor dynamics. Additional experience includes research assistant positions at Harvard University and other internships, with a strong academic background holding a Master of Science in Bioinformatics and a Bachelor of Science in Neuroscience from Northeastern University.
This person is not in any offices
Medicinal Genomics
Medicinal Genomics is pioneering the genomics of medical cannabis and hemp. In 2011, Medicinal Genomics made worldwide headlines for being the first group to decode the Cannabis Genome. An increasing amount of scientific evidence supports the theory that cannabinoid compounds may have numerous medical benefits. Medicinal Genomics has the largestDNA sequence database of the cannabis plant and is well-positioned to design fingerprinting assays for strain genotyping and sequencing services for strain development. In 2011, Medicinal Genomics was acquired by Courtagen Life Sciences, Inc.